{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:27:56Z","timestamp":1787027276564,"version":"build-2736575974"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Fluvoxamine is widely used to treat depression during pregnancy and lactation. However, limited data are available on its transfer to the fetus or in human milk. This case series provides additional information on the infant exposure to fluvoxamine during pregnancy and lactation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>Two women, aged 38 and 34 years, diagnosed with depression were treated with 50 mg fluvoxamine during pregnancy and lactation. At delivery a paired maternal and cord blood sample was collected for each woman. The first mother exclusively breastfed her child for 4 months and gave one foremilk and one hindmilk sample at 2 days and 4 weeks post-partum, whereas the second mother did not breastfeed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cord to plasma concentration ratios were 0.62 and 0.48, respectively. At 2 weeks post-partum, relative infant doses (RID) were 0.47 and 0.57% based on fluvoxamine concentrations in foremilk and hindmilk, respectively. At 4 weeks post-partum, the RIDs were 0.35 and 0.90%, respectively. The child from the first mother was born healthy and showed a normal development at the 6th, 18th and 36th month follow-ups. One of the twins from the second woman was hospitalized for hypoglycemia that was attributed to gestational diabetes and low birth weight. The second one was born healthy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These results suggest a minimal exposure to fluvoxamine during lactation which is in accordance with previously published data. Larger clinical and pharmacokinetic studies assessing the long-term safety of this drug during lactation and the variability of its exposure through breastmilk are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1167870","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T04:06:52Z","timestamp":1684382812000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project"],"prefix":"10.3389","volume":"14","author":[{"given":"Ana\u00eblle","family":"Monfort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin B.","family":"Eap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line J.","family":"Fischer Fumeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam Bickle","family":"Graz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Morisod Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Weisskopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Gandia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Nordeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Hasco\u00ebt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Claris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuella","family":"Epiney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Csajka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ema","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Panchaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-199500291-00003","article-title":"Overview of the pharmacokinetics of fluvoxamine","volume":"29","author":"van Harten","year":"1995","journal-title":"Clin Pharmacokinet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.9740\/mhc.n163520","article-title":"Use of antidepressants during pregnancy and lactation","volume":"3","author":"Norris","year":"2013","journal-title":"Mental Health Clinician."},{"key":"B3","unstructured":"Drugs and Lactation Database (LactMed2006"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/S0006-3223(00)00958-6","article-title":"Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women","volume":"48","author":"Hostetter","year":"2000","journal-title":"Biol Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1055\/s-0028-1103296","article-title":"Placental transfer of SSRI and SNRI antidepressants and effects on the neonate","volume":"42","author":"Rampono","year":"2009","journal-title":"Pharmacopsychiatry."},{"key":"B6","doi-asserted-by":"publisher","first-page":"994","DOI":"10.4088\/JCP.10m06461","article-title":"Mother-infant antidepressant concentrations, maternal depression, and perinatal events","volume":"72","author":"Sit","year":"2011","journal-title":"J Clin Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2125.1991.tb05519.x","article-title":"Excretion of fluvoxamine in breast milk","volume":"31","author":"Wright","year":"1991","journal-title":"Br J Clin Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/bcp.1997.44.2.210","article-title":"Fluvoxamine in breast-milk and infant development","volume":"44","author":"Yoshida","year":"1997","journal-title":"Br J Clin Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/00004714-200008000-00018","article-title":"Fluvoxamine concentrations in breast milk and in maternal and infant sera","volume":"20","author":"Arnold","year":"2000","journal-title":"J Clin Psychopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1046\/j.1365-2125.2000.00142-3.x","article-title":"Excretion of fluvoxamine into breast milk","volume":"49","author":"Hagg","year":"2000","journal-title":"Br J Clin Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1176\/appi.ajp.161.6.1066","article-title":"Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants","volume":"161","author":"Weissman","year":"2004","journal-title":"Am J Psychiatry."},{"key":"B12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/089033440201800205","article-title":"The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants","volume":"18","author":"Kristensen","year":"2002","journal-title":"J Hum Lact."},{"key":"B13","volume-title":"Bayley Scales of Infant and Toddler Development","author":"Bayley","year":"2006"},{"key":"B14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jchromb.2017.04.039","article-title":"Simultaneous determination of selective serotonin reuptake inhibitors and their main metabolites in human breast milk by liquid chromatography-electrospray mass spectrometry","volume":"1057","author":"Weisskopf","year":"2017","journal-title":"J. Chromatograph. B."},{"key":"B15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jchromb.2011.12.028","article-title":"Simultaneous quantification of selective serotonin reuptake inhibitors and metabolites in human plasma by liquid chromatography\u2013electrospray mass spectrometry for therapeutic drug monitoring","volume":"885","author":"Ansermot","year":"2012","journal-title":"J. Chromat. B"},{"key":"B16","unstructured":"Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation.2018"},{"key":"B17","unstructured":"ICH guideline M10 on Bioanalytical Method Validation Study Sample Analysis.2018"},{"key":"B18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11095-017-2287-z","article-title":"Drugs in Lactation","volume":"35","author":"Anderson","year":"2018","journal-title":"Pharm Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","article-title":"Drug transfer and metabolism by the human placenta","volume":"43","author":"Syme","year":"2004","journal-title":"Clin Pharmacokinet."},{"key":"B20","first-page":"51","article-title":"Neonatal hypoglycemia screening in newborns from diabetic mothers\u2013arguments and controversies","volume":"7","author":"Stanescu","year":"2014","journal-title":"J Med Life"},{"key":"B21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1600-0447.2009.01490.x","article-title":"register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health","volume":"121","author":"Warburton","year":"2010","journal-title":"Acta Psychiatr Scand."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/nu11071525","article-title":"Longitudinal analysis of macronutrient composition in preterm and term human milk: a prospective cohort study","volume":"11","author":"Fischer Fumeaux","year":"2019","journal-title":"Nutrients."},{"key":"B23","volume-title":"Breastfeeding and Human Lactation","author":"Wambach","year":"2021"},{"key":"B24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/cpt.377","article-title":"Modeling drug passage into human milk","volume":"100","author":"Anderson","year":"2016","journal-title":"Clin Pharmacol Ther."},{"key":"B25","unstructured":"Le\u00f3n-CavaN\n            LutterC\n            RossJ\n            MartinL\n          35679837Quantifying the Benefits of Breastfeeding: A Summary of the Evidence.2021"},{"key":"B26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1177\/0269881110370504","article-title":"CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype\u2013phenotype association study design in translational pharmacogenetics","volume":"25","author":"Suzuki","year":"2011","journal-title":"J. Psychopharmacol."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1167870\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T04:06:59Z","timestamp":1684382819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1167870\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":26,"alternative-id":["10.3389\/fpsyt.2023.1167870"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1167870","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"article-number":"1167870"}}